About Penta
Who we are
Penta ID Network
Penta Foundation Italy
Penta Foundation UK
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Publications
Contact us
Work with us
Vacancies
Call for services
Archivio
The challenge of the laboratory diagnosis in a confirmed congenital Zika virus syndrome in utero: a case report
Let’s talk about antimicrobial resistance: Penta at European Researchers’ Night
Uniting against antibiotic resistance: ‘5 by 25’
Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial-a study protocol
Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years – evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
c4c pool of expert patients: get involved!
Pharmacokinetics of dolutegravir 5mg dispersible tablets in children weighing 6 to <20kg dosed using WHO weight bands
Follow up of Children with Confirmed Perinatal Zika Virus (ZIKV) Exposure: The First 2 years-experience in the Costa Rican Tertiary Pediatric Hospital
Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus
The CARMA Study: Children on early suppressive ART Total HIV-1 DNA quantitation 12 years post ART initiation
Comparison of qPCR and dPCR methods to investigate the latent HIV reservoir in a paediatric population with long viral suppression on therapy
Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children